These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8218842)

  • 1. Pathogenesis of IDDM: immune regulation and induction of immune tolerance in the NOD mouse.
    Boitard C; Timsit J; Larger E; Sempé P; Bach JF
    Autoimmunity; 1993; 15 Suppl():12-3. PubMed ID: 8218842
    [No Abstract]   [Full Text] [Related]  

  • 2. The regulation of autoimmunity through CD4+ T cells.
    Hutchings P; Parish N; O'Reilly L; Dawe K; Roitt IM; Cooke A
    Autoimmunity; 1993; 15 Suppl():21-3. PubMed ID: 8105991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet xenotransplantation.
    Gill RG
    Autoimmunity; 1993; 15 Suppl():18-20. PubMed ID: 8218845
    [No Abstract]   [Full Text] [Related]  

  • 4. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
    Toyoda H; Formby B
    Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice.
    Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M
    Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
    Yoon JW; Jun HS
    Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulatory phenomena in tolerance induction].
    Salaün J
    J Soc Biol; 2002; 196(4):259-61. PubMed ID: 12645291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early intervention in insulin-dependent diabetes mellitus.
    Cahill GF
    Curr Probl Clin Biochem; 1983; 12():108-18. PubMed ID: 6418442
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-dependent diabetes mellitus as an autoimmune disease.
    Bach JF
    Endocr Rev; 1994 Aug; 15(4):516-42. PubMed ID: 7988484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [One step towards restoration of self-tolerance in human autoimmune diseases].
    Chatenoud L
    Med Sci (Paris); 2007 Feb; 23(2):167-71. PubMed ID: 17291426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune disorders in diabetes.
    Boitard C; Debray-Sachs M; Bach JF
    Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune islet damage mediated by insulin-specific T cells.
    Crawford M; Daniel D; Wegmann D; Yang H; Gill RG
    Transplant Proc; 1997; 29(1-2):758-9. PubMed ID: 9123512
    [No Abstract]   [Full Text] [Related]  

  • 14. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha.
    Pakala SV; Chivetta M; Kelly CB; Katz JD
    J Exp Med; 1999 Apr; 189(7):1053-62. PubMed ID: 10190896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.
    Mellanby RJ; Thomas D; Phillips JM; Cooke A
    Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?
    Rabinovitch A
    Diabetes; 1994 May; 43(5):613-21. PubMed ID: 8168635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Questions about NOD mouse diabetes.
    Cohen IR
    Res Immunol; 1997 Jun; 148(5):286-91. PubMed ID: 9352591
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
    Reddy S; Liu W; Elliott RB
    Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deviation of islet autoreactivity to cryptic epitopes protects NOD mice from diabetes.
    Song A; Winer S; Tsui H; Sampson A; Pasceri P; Ellis J; Elliott JF; Dosch HM
    Eur J Immunol; 2003 Feb; 33(2):546-55. PubMed ID: 12645954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.